These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8607386)

  • 1. A symposium: Supraventricular Arrhythmias: Update 1995. Boston, Massachusetts, May 6, 1995.
    Am J Cardiol; 1996 Jan; 77(3):1A-95A. PubMed ID: 8607386
    [No Abstract]   [Full Text] [Related]  

  • 2. [Flecainide and anti-arrhythmia therapy].
    Croce L; Romano S; Pozzoni L; Lomuscio A
    Minerva Med; 1988 Mar; 79(3):229-34. PubMed ID: 3129677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Supraventricular extrasystole after cardioversion with amiodarone].
    Meinertz T
    Dtsch Med Wochenschr; 2012 Jul; 137(28-29):1475. PubMed ID: 22760409
    [No Abstract]   [Full Text] [Related]  

  • 4. Flecainide acetate for the treatment of atrial and ventricular arrhythmias.
    Apostolakis S; Oeff M; Tebbe U; Fabritz L; Breithardt G; Kirchhof P
    Expert Opin Pharmacother; 2013 Feb; 14(3):347-57. PubMed ID: 23294160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flecainide for supraventricular tachyarrhythmias.
    Med Lett Drugs Ther; 1992 Jul; 34(875):71-2. PubMed ID: 1630411
    [No Abstract]   [Full Text] [Related]  

  • 6. Guidelines for the use of flecainide in patients with supraventricular arrhythmias.
    Smith W; Crozier I; McAlister H; O'Meeghan T; Stewart F
    N Z Med J; 2000 Oct; 113(1119):420-1. PubMed ID: 11127360
    [No Abstract]   [Full Text] [Related]  

  • 7. Neonatal flecainide toxicity following supraventricular tachycardia treatment.
    Hall CM; Ward Platt MP
    Ann Pharmacother; 2003 Sep; 37(9):1343-4. PubMed ID: 12921523
    [No Abstract]   [Full Text] [Related]  

  • 8. Fetal and maternal magnetocardiography during flecainide therapy for supraventricular tachycardia.
    Campbell JQ; Best TH; Eswaran H; Lowery CL
    Obstet Gynecol; 2006 Sep; 108(3 Pt 2):767-71. PubMed ID: 17018496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of paroxysmal supraventricular arrhythmias in IHD patients with a high risk of developing complications from the anti-arrhythmic therapy].
    Andriushchenko OM; Olesin AI
    Ter Arkh; 1996; 68(5):57-60. PubMed ID: 9082603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Termination of atrial fibrillation by flecainide: mechanistic insights from spectral analysis.
    Hunter RJ; Schilling RJ
    Europace; 2010 Apr; 12(4):453-4. PubMed ID: 20167613
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical use of intravenous amiodarone for supraventricular arrhythmias].
    Assadi S; Edoute Y
    Harefuah; 1995 Dec; 129(12):583-6. PubMed ID: 8682364
    [No Abstract]   [Full Text] [Related]  

  • 12. Meta-analysis of flecainide safety in patients with supraventricular arrhythmias.
    Wehling M
    Arzneimittelforschung; 2002; 52(7):507-14. PubMed ID: 12189773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the use of flecainide acetate in the long-term management of cardiac arrhythmias.
    Wiseman MN; Elstob JE; Camm AJ; Nathan AW
    Pacing Clin Electrophysiol; 1990 Jun; 13(6):767-75. PubMed ID: 1695357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of drugs in the long-term management of cardiac arrhythmias].
    Huikuri H
    Duodecim; 1992; 108(13):1158-60. PubMed ID: 1366068
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of supraventricular tachyarrhythmias: drugs or ablation?].
    Chimienti M; Barbieri S
    G Ital Cardiol; 1996 Feb; 26(2):213-26. PubMed ID: 8666179
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemolysis alters plasma flecainide levels in newborn infants.
    Vento M; Tudela BF; Escrig R; Sáenz P; Sánchez A; Cano A
    Acta Paediatr; 2007 Mar; 96(3):466-8. PubMed ID: 17407483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of a "bystander" concealed accessory pathway in the response to verapamil and flecainide treatment in a patient with nodal reentry tachycardia].
    Matteucci C; Busi G
    G Ital Cardiol; 1996 Apr; 26(4):419-25. PubMed ID: 8707026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [How to treat patients with non-life-threatening arrhythmia symptoms].
    O'Hara G
    Can J Cardiol; 1994 Apr; 10(3):331-2. PubMed ID: 7512884
    [No Abstract]   [Full Text] [Related]  

  • 19. [European protocol for the management of fetal supraventricular tachycardia. European Association of Pediatric Cardiology].
    Azancot-Benisty A; Areias JC; Oberhänsli I; Schmidt KG; Tulzer G; Viart P
    Arch Mal Coeur Vaiss; 1997 May; 90(5):735-43. PubMed ID: 9295960
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of maternal flecainide concentration in management of fetal supraventricular tachycardia: a step in the right direction.
    Cuneo BF; Benson DW
    Heart Rhythm; 2014 Nov; 11(11):2054-5. PubMed ID: 25128734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.